13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q3 2025 · Filed November 12, 2025 · Accession 0001193125-25-277944
Total Value
$81.3M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,266,934 | $55.0M | 67.66% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 1,008,116 | $16.4M | 20.13% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $9.9M | 12.21% |